Host cell targets for antiviral therapy:: an update

被引:4
|
作者
DeFilippis, Victor [1 ]
Frueh, Klaus [1 ]
机构
[1] Oregon Hlth & Sci Univ, Vaccine & Gene Therapy Inst, Beaverton, OR 97006 USA
关键词
cholesterol pathway; endocytosis farnesyl; geranyl-geranyl; Gleevec((R)); small interfering; RNA; statin; therapeutic targets;
D O I
10.2217/17460794.1.4.509
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
The discovery of antiviral therpeutic targets has traditionally focussed on conserved viral gene products. Since viruses are obligate molecular parasites requiring and manipulating host cell functions, the identification of host proteins essential to viruses but not cellular survival represent attractive and underutilized targets for antiviral therapies. Numerous studies have identified host cell functions, pathways and proteins that are essential for viral propagation, from entry to replication, assembly and egress. Importantly, several studies demonstrate virus inhibition through nonlethal impairment of host cell function both in vitro and in vivo. In addition, high-throughput experimental platforms allowing global or nearglobal surveillance of host gene products in the context of virus replication are now being used to systematically identify host cell targets. Recent breakthrough studies that have employed such methods successfully to identify host proteins and pathways crucial for virus growth are discussed in this review.
引用
收藏
页码:509 / 518
页数:10
相关论文
共 50 条
  • [1] Host Cell Factors as Antiviral Targets in Arenavirus Infection
    Linero, Florencia N.
    Sepulveda, Claudia S.
    Giovannoni, Federico
    Castilla, Viviana
    Garcia, Cybele C.
    Scolaro, Luis A.
    Damonte, Elsa B.
    VIRUSES-BASEL, 2012, 4 (09): : 1569 - 1591
  • [2] MOLECULAR TARGETS OF ANTIVIRAL THERAPY
    CRUMPACKER, CS
    NEW ENGLAND JOURNAL OF MEDICINE, 1989, 321 (03): : 163 - 172
  • [3] Emerging host cell targets for hepatitis C therapy
    He, Yupeng
    Duan, Wei
    Tan, Seny-Lai
    DRUG DISCOVERY TODAY, 2007, 12 (5-6) : 209 - 217
  • [4] Targets for Antiviral Therapy of Hepatitis C
    Rupp, Daniel
    Bartenschlager, Ralf
    SEMINARS IN LIVER DISEASE, 2014, 34 (01) : 9 - 21
  • [5] Harnessing host enhancers of SARS-CoV-2 entry as novel targets for antiviral therapy
    Williams, Nathalia
    Silva, Filo
    Schmolke, Mirco
    ANTIVIRAL RESEARCH, 2024, 228
  • [6] Entry of influenza A virus: host factors and antiviral targets
    Edinger, Thomas O.
    Pohl, Marie O.
    Stertz, Silke
    JOURNAL OF GENERAL VIROLOGY, 2014, 95 : 263 - 277
  • [7] Host-Directed Antiviral Therapy
    Kumar, Naveen
    Sharma, Shalini
    Kumar, Ram
    Tripathi, Bhupendra N.
    Barua, Sanjay
    Hinh Ly
    Rouse, Barry T.
    CLINICAL MICROBIOLOGY REVIEWS, 2020, 33 (03)
  • [8] An update on stem cell therapy for neurological disorders: Cell death pathways as therapeutic targets
    Corey S.
    Ghanekar S.
    Sokol J.
    Zhang J.H.
    Borlongan C.V.
    Chinese Neurosurgical Journal, 3 (1)
  • [9] An update on stem cell therapy for neurological disorders: cell death pathways as therapeutic targets
    Corey Sydney
    Ghanekar Shaila
    Sokol Jake
    Zhang John H
    Borlongan Cesar V
    中华神经外科杂志(英文), 2017, (02) : 98 - 105
  • [10] A screening assay for the identification of host cell requirements and antiviral targets for hepatitis D virus infection
    Buchmann, Bettina
    Doehner, Katinka
    Schirdewahn, Thomas
    Sodeik, Beate
    Manns, Michael P.
    Wedemeyer, Heiner
    Ciesek, Sandra
    von Hahn, Thomas
    ANTIVIRAL RESEARCH, 2017, 141 : 116 - 123